Michael Deligny

Michael Deligny has a diverse work experience in the pharmaceutical industry. Michael started their career as a postdoc at CEA in 2005 and worked there until 2007. Michael then joined UCB as an R&D senior scientist from 2007 to 2015. At UCB, they later became a Principal Scientist Medicinal Chemistry from 2015 to 2017. Currently, they are working as a Principal Scientist, Drug Discovery at iTeos Therapeutics SA since 2017.

Michael Deligny attended Université de Rennes I from 2000 to 2003 but did not complete a degree or specify a field of study. Michael also attended Université de Rouen at an unspecified time, but no further details about their education at this institution are available.